Introduction: Prescription of second-generation antipsychotics (SGAs) in youth is rapidly increasing globally and in Australia. Lack of timely metabolic monitoring for potential adverse effects puts youth at greater risk for lifelong adverse health impact. Metabolic monitoring is recommended as best practice to prevent and/or manage SGA-induced weight gain/metabolic syndrome. The adherence to clinical guidelines remains suboptimal. It is crucial to gauge insight to challenges and strategies from the perspective of prescribers and to recommend strategies in promoting quality use of SGAs and adherence to pharmacovigilance standards.

中文翻译：

---

从业者对第二代抗精神病药物代谢监测的看法：知识差距、监测障碍和策略

简介：在全球和澳大利亚，青少年第二代抗精神病药物 (SGA) 的处方正在迅速增加。缺乏对潜在不利影响的及时代谢监测会使青少年面临更大的终生不利健康影响风险。建议将代谢监测作为预防和/或管理 SGA 引起的体重增加/代谢综合征的最佳实践。对临床指南的依从性仍然欠佳。从处方者的角度衡量对挑战和策略的洞察力，并推荐策略以促进 SGA 的质量使用和遵守药物警戒标准，这一点至关重要。